fda warning compounding semaglutide october 2025 Warns on Certain Forms of Compounded Drugmakers battle pharmacies over compounded

Neuropharmacology 170 , 108042 (2020)

Suddenly, individuals without diabetes were seeking the medication as a weight loss aid, leading to a surge in off-label use

Given the similarities between the brain's and retina's vascular systems, these findings suggest that GLP-1R agonism could also protect the brain's microvasculature, preserving the integrity of the blood-brain barrier and improving cerebral blood flow

The research linking these ingredients to potential weight management and GLP-1 support is still in the early stages, and the studies that currently exist are quite small and not very robust, explains Lorenz